Literature DB >> 18810632

Low grade inflammation, as evidenced by basal high sensitivity CRP, is not correlated to outcome measures in IVF.

Sarah Robinson1, Phil Pemberton, Ian Laing, Luciano G Nardo.   

Abstract

PURPOSE: To assess the relationship between low-grade inflammation, measured as basal high sensitivity (hs)-CRP, and IVF outcome.
METHODS: We recruited a total of 220 women undergoing infertility work up prior to IVF. Patients were selected for a BMI < 30 kg/m(2) with an upper age limit of 40 years. Serum hs-CRP levels were measured on day 3 of a spontaneous menstrual cycle preceding ovarian stimulation. A sensitive two-site ELISA was used for analysis. Dose of gonadotrophins required, follicles days 8 and 10, number of oocytes collected, number of oocytes fertilised and pregnancy outcome were recorded.
RESULTS: Median hs-CRP was 1.08 mg/L (0.43-3.00 mg/L). The hs-CRP was significantly related to BMI (r = 0.386, P < .001) but not to age and smoking habit. There were no significant relationships between basal hs-CRP and any of the measured IVF outcomes.
CONCLUSIONS: These findings demonstrate that serum hs-CRP concentration is not a predictive marker of cycle or pregnancy outcome in women undergoing IVF treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18810632      PMCID: PMC2582128          DOI: 10.1007/s10815-008-9253-y

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  29 in total

1.  Elevated C-reactive protein levels in overweight and obese adults.

Authors:  M Visser; L M Bouter; G M McQuillan; M H Wener; T B Harris
Journal:  JAMA       Date:  1999-12-08       Impact factor: 56.272

2.  [Obesity and reproductive disorders].

Authors:  K Krizanovská; Z Ulcová-Gallová; V Bouse; Z Rokyta
Journal:  Sb Lek       Date:  2002

3.  Does body mass index of infertile women have an impact on IVF procedure and outcome?

Authors:  C Wittemer; J Ohl; M Bailly; K Bettahar-Lebugle; I Nisand
Journal:  J Assist Reprod Genet       Date:  2000-11       Impact factor: 3.412

4.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

Authors:  A D Pradhan; J E Manson; N Rifai; J E Buring; P M Ridker
Journal:  JAMA       Date:  2001-07-18       Impact factor: 56.272

Review 5.  Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells.

Authors:  John N Fain
Journal:  Vitam Horm       Date:  2006       Impact factor: 3.421

6.  The levels of C-reactive protein in women treated by IVF.

Authors:  Miriam Almagor; Albert Hazav; Haim Yaffe
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

7.  Higher C-reactive protein levels during IVF stimulation are associated with ART failure.

Authors:  Ishai Levin; Ronni Gamzu; Roy Mashiach; Joseph B Lessing; Ami Amit; Benny Almog
Journal:  J Reprod Immunol       Date:  2007-04-27       Impact factor: 4.054

8.  Maternal C-reactive protein levels are raised at 4 weeks gestation.

Authors:  G P Sacks; L Seyani; S Lavery; G Trew
Journal:  Hum Reprod       Date:  2004-02-27       Impact factor: 6.918

9.  C-reactive protein levels in patients undergoing controlled ovarian hyperstimulation for IVF cycle.

Authors:  Raoul Orvieto; Roni Chen; Jacob Ashkenazi; Avi Ben-Haroush; Avi Ben-Harush; Jacob Bar; Benjamin Fisch
Journal:  Hum Reprod       Date:  2004-02       Impact factor: 6.918

Review 10.  Impact of obesity on female reproductive health: British Fertility Society, Policy and Practice Guidelines.

Authors:  Adam H Balen; Richard A Anderson
Journal:  Hum Fertil (Camb)       Date:  2007-12       Impact factor: 2.767

View more
  8 in total

1.  C-Reactive protein in relation to fecundability and anovulation among eumenorrheic women.

Authors:  Rose G Radin; Lindsey A Sjaarda; Robert M Silver; Carrie J Nobles; Sunni L Mumford; Neil J Perkins; Brian D Wilcox; Anna Z Pollack; Karen C Schliep; Torie C Plowden; Enrique F Schisterman
Journal:  Fertil Steril       Date:  2018-01-06       Impact factor: 7.329

2.  The effect of serum and follicular fluid secreted frizzle-related protein-5 on in vitro fertilization outcomes in patients with polycystic ovary syndrome.

Authors:  Zeynep Ozturk Inal; Hasan Ali Inal; Sami Erdem
Journal:  Mol Biol Rep       Date:  2018-09-07       Impact factor: 2.316

3.  The effect of serum and follicular fluid amyloid-associated protein levels on in vitro fertilization outcome in patients with polycystic ovary syndrome.

Authors:  Hakan Timur; Nafiye Yimaz; Inci Kahyaoglu; Hasan Ali Inal; Salim Erkaya
Journal:  J Assist Reprod Genet       Date:  2015-10-10       Impact factor: 3.412

Review 4.  Maternal C-reactive protein and in vitro fertilization (IVF) cycles.

Authors:  Fatemeh Diba-Bagtash; Azizeh Farshbaf-Khalili; Alyeh Ghasemzadeh; Laura Lotz; Amir Fattahi; Mahnaz Shahnazi; Ralf Dittrich
Journal:  J Assist Reprod Genet       Date:  2020-08-15       Impact factor: 3.412

5.  Preconception Low-Dose Aspirin Restores Diminished Pregnancy and Live Birth Rates in Women With Low-Grade Inflammation: A Secondary Analysis of a Randomized Trial.

Authors:  Lindsey A Sjaarda; Rose G Radin; Robert M Silver; Emily Mitchell; Sunni L Mumford; Brian Wilcox; Noya Galai; Neil J Perkins; Jean Wactawski-Wende; Joseph B Stanford; Enrique F Schisterman
Journal:  J Clin Endocrinol Metab       Date:  2017-05-01       Impact factor: 5.958

Review 6.  Role of Inflammaging on the Reproductive Function and Pregnancy.

Authors:  Alice Zavatta; Francesca Parisi; Chiara Mandò; Chiara Scaccabarozzi; Valeria M Savasi; Irene Cetin
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-15       Impact factor: 8.667

7.  High-sensitivity C-reactive protein levels and pregnancy outcomes in women with unexplained infertility after ovarian stimulation with intrauterine insemination in a multicenter trial.

Authors:  Sarah Z Gavrizi; Sushila Arya; Jennifer D Peck; Jennifer F Knudtson; Michael P Diamond; Robert A Wild; Karl R Hansen
Journal:  F S Rep       Date:  2022-01-11

Review 8.  Impact of contraception and IVF hormones on metabolic, endocrine, and inflammatory status.

Authors:  Ayla Coussa; Hayder A Hasan; Thomas M Barber
Journal:  J Assist Reprod Genet       Date:  2020-03-25       Impact factor: 3.412

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.